0
我需要幫助優化批處理文件以將多個xml文件的多個xml文件轉換爲.txt或.csv文件。批處理文件提取許多.xml文件的xml標記的值
.xml的格式都是相同的。他們的臨牀研究，並期待這樣的：
<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="373">
<!-- This xml conforms to an XML Schema at:
https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
<required_header>
<download_date>ClinicalTrials.gov processed this data on May 25, 2017</download_date>
<link_text>Link to the current ClinicalTrials.gov record.</link_text>
<url>https://clinicaltrials.gov/show/NCT00146471</url>
</required_header>
<id_info>
<org_study_id>Kep-F10.3.01</org_study_id>
<nct_id>NCT00146471</nct_id>
</id_info>
<brief_title>Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome</brief_title>
<official_title>Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome [Sicherheit Und Wirksamkeit Von Levetiracetam (Keppra) für Die Behandlung Des stationären Alkoholentzugsyndroms]</official_title>
<sponsors>
<lead_sponsor>
<agency>Charite University, Berlin, Germany</agency>
<agency_class>Other</agency_class>
</lead_sponsor>
</sponsors>
<source>Charite University, Berlin, Germany</source>
<oversight_info>
<has_dmc>Yes</has_dmc>
</oversight_info>
<brief_summary>
<textblock>
The purpose of this study is to evaluate the efficacy and safety of levetiracetam for
treating alcohol withdrawal syndrome (AWS) in inpatients (vs. placebo). The primary come-out
parameter is the reduction of the total needed amount of diazepam for add-on treatment of
acute alcohol withdrawal symptoms. The secondary come-out parameter are - safety criteria
(AE) - reduction of alcohol withdrawal score over the days.
</textblock>
</brief_summary>
<overall_status>Completed</overall_status>
<start_date>January 2006</start_date>
<completion_date type="Actual">September 2007</completion_date>
<primary_completion_date type="Actual">July 2007</primary_completion_date>
<phase>Phase 3</phase>
<study_type>Interventional</study_type>
<has_expanded_access>No</has_expanded_access>
<study_design_info>
<allocation>Randomized</allocation>
<intervention_model>Parallel Assignment</intervention_model>
<primary_purpose>Treatment</primary_purpose>
<masking>Double Blind (Participant, Care Provider, Investigator)</masking>
</study_design_info>
<primary_outcome>
<measure>To evaluate the efficacy and safety of levetiracetam for treating alcohol withdrawal syndrome in inpatients. The primary come-out parameter is the reduction of the amount of diazepam for add-on treatment of acute alcohol withdrawal</measure>
<time_frame>during trial</time_frame>
</primary_outcome>
<secondary_outcome>
<measure>Secondary come-out parameters are - safety criteria (AE) - reduction of alcohol withdrawal score over the days</measure>
<time_frame>during trial</time_frame>
</secondary_outcome>
<number_of_arms>2</number_of_arms>
<enrollment type="Actual">120</enrollment>
<condition>Alcohol Withdrawal Syndrome</condition>
<arm_group>
<arm_group_label>2</arm_group_label>
<arm_group_type>Active Comparator</arm_group_type>
</arm_group>
<arm_group>
<arm_group_label>1: Diazepam plus Placebo</arm_group_label>
<arm_group_type>Placebo Comparator</arm_group_type>
</arm_group>
<intervention>
<intervention_type>Drug</intervention_type>
<intervention_name>Levetiracetam</intervention_name>
<description>1500-2000 mg daily add-on or Placebo Diazepam as needed</description>
<arm_group_label>2</arm_group_label>
<other_name>KEPPRA</other_name>
</intervention>
<intervention>
<intervention_type>Drug</intervention_type>
<intervention_name>Placebo</intervention_name>
<description>1500-2000 mg daily add-on or Placebo Diazepam as needed</description>
<arm_group_label>1: Diazepam plus Placebo</arm_group_label>
</intervention>
<eligibility>
<criteria>
<textblock>
Inclusion Criteria:
- Ages eligible for study: 18-65 years.
- Meets criteria for alcohol dependence according to DSM-IV/ICD-10
- Known withdrawal symptoms in the past in case of discontinuation of alcohol
consumption
- Hospital admission for alcohol detoxification
- Able to provide a written informed consent.
- Able to follow verbal and written instructions (incl. a sufficient knowledge of
German language).
- Must be medically acceptable for study treatment. No past or present physical
disorder that is likely to deteriorate during participation. No ECG abnormality which
would likely worsen during participation and no clinical laboratory abnormality that
would also suggest deterioration during treatment.
- Have a negative urine drug screen for benzodiazepines or heroine or methadone
Exclusion Criteria:
- Current diagnosis of any other substance dependence syndrome other than alcohol
dependence (excluding nicotine and caffeine dependence).
- History of idiopathic epilepsy.
- Patient with any current clinically significant psychiatric disorder (acute
suiciality) or developmental disorder (including organic mental disorder), like
psychotic disorders.
- Patients with the following complications of alcoholism (lifetime): acute delirium
tremens, hallucinatory alcoholic state, Korsakoff`s syndrome, Wernicke
encephalopathy, decomposed liver cirrhosis (Child B, C), suspected cirrhosis with the
following clinical symptoms detected at clinical exam: signs of portal hypertension
and signs of hepato-cellular failure, thrombocytopenia.
- Subjects with known sensitivity of previous adverse reaction to levetiracetam
- Contra-indication (hypersensitivity to levetiracetam or pyrrolidone derivatives) or
known non-response to levetiracetam.
- History of severe GI disease which might render absorption of the medication
difficult or produce medical instability of the patient which would include active
peptic ulcer disease, ulcerative colitis, regional colitis, or evidence by history or
physical exam of GI bleeding.
- Patients with any clinically significant acute or chronic progressive neurological,
gastrointestinal, cardiovascular, hepatic, renal, haematological, endocrine,
dermatological or respiratory disease, such as diabetes, severe infection, acute
alcoholic hepatitis, or any other medical condition with significant worsening of the
clinical situation of the patient that might interfere with the evaluation of study
medication.
- Female patients pregnant, breast-feeding or of child bearing age and not protected by
effective contraceptive such as implants, injectables, combined oral contraceptives,
some IUDS, sexual abstinence, sterilization or vasectomized partner.
- Actually continuous use of pharmacological agents that are known to lower the seizure
threshold or augment or decrease the alcohol withdrawal syndrome.
- Subjects with known sensitivity of previous adverse reaction to diazepam or clonidine
- Contra-indication or known non-response to diazepam or clonidine
</textblock>
</criteria>
<gender>All</gender>
<minimum_age>18 Years</minimum_age>
<maximum_age>65 Years</maximum_age>
<healthy_volunteers>No</healthy_volunteers>
</eligibility>
<overall_official>
<last_name>Martin Schaefer, MD</last_name>
<role>Principal Investigator</role>
<affiliation>Charité Campus Mitte, Klinik für Psychiatrie und Psychotherapie</affiliation>
</overall_official>
<location>
<facility>
<name>MLU Halle-Wittenberg</name>
<address>
<city>Halle</city>
<state>Sachen/Anhalt</state>
<zip>06097</zip>
<country>Germany</country>
</address>
</facility>
</location>
<location>
<facility>
<name>Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Klinik für Psychiatrie und Psychotherapie</name>
<address>
<city>Berlin</city>
<zip>10117</zip>
<country>Germany</country>
</address>
</facility>
</location>
<location>
<facility>
<name>Psychiatrische Klinik der Charité im St.-Hedwig Krankenhaus</name>
<address>
<city>Berlin</city>
<zip>10559</zip>
<country>Germany</country>
</address>
</facility>
</location>
<location>
<facility>
<name>Klinik für Psychiatrie und Suchtmedizin, Kliniken Essen Mitte</name>
<address>
<city>Essen</city>
<zip>45136</zip>
<country>Germany</country>
</address>
</facility>
</location>
<location>
<facility>
<name>Zentrum für Seelische Gesundheit</name>
<address>
<city>Rhede</city>
<zip>46414</zip>
<country>Germany</country>
</address>
</facility>
</location>
<location_countries>
<country>Germany</country>
</location_countries>
<reference>
<citation>Krebs M, Leopold K, Richter C, Kienast T, Hinzpeter A, Heinz A, Schaefer M. Levetiracetam for the treatment of alcohol withdrawal syndrome: an open-label pilot trial. J Clin Psychopharmacol. 2006 Jun;26(3):347-9.</citation>
<PMID>16702910</PMID>
</reference>
<verification_date>September 2008</verification_date>
<lastchanged_date>December 29, 2009</lastchanged_date>
<firstreceived_date>September 6, 2005</firstreceived_date>
<responsible_party>
<name_title>Martin Schaefer, MD</name_title>
<organization>Charite University, Berlin, Germany</organization>
</responsible_party>
<keyword>alcohol withdrawal</keyword>
<keyword>detoxification</keyword>
<keyword>Inpatients</keyword>
<keyword>alcohol dependence according to DSM-IV/ICD-10</keyword>
<keyword>withdrawal symptoms</keyword>
<condition_browse>
<!-- CAUTION: The following MeSH terms are assigned with an imperfect algorithm -->
<mesh_term>Syndrome</mesh_term>
<mesh_term>Substance Withdrawal Syndrome</mesh_term>
</condition_browse>
<intervention_browse>
<!-- CAUTION: The following MeSH terms are assigned with an imperfect algorithm -->
<mesh_term>Ethanol</mesh_term>
<mesh_term>Diazepam</mesh_term>
<mesh_term>Etiracetam</mesh_term>
<mesh_term>Piracetam</mesh_term>
</intervention_browse>
<!-- Results have not yet been posted for this study -->
</clinical_study>
所以他們都使用相同的標記，我需要一些他們喜歡：
- overall_official
- lead_sponsor
- official_title
- results_reference
- overall_status
到目前爲止，我試着用下面的代碼：
@echo off
setlocal enabledelayedexpansion
for %%a in (*.xml) do (
call :XMLExtract "%%a" "<results_reference>" location
echo.!location!,%%~na
)
exit /b
:XMLExtract file keystart location
@echo off & setlocal
for /f "tokens=3 delims=<>" %%a in ('Findstr /i /c:%2 "%~1"') do (
set "loc=%%a" & goto :endloop
)
:endLoop
ENDLOCAL & IF "%~3" NEQ "" (SET %~3=%loc%) ELSE echo.%loc%
exit /b
我跑在命令行批：蝙蝠>> output.txt中或output.csv它完美地工作了overall_status，但所有其它標籤有問題，例如：
- overall_offical：它停止後像他們一樣的10
- 其他標籤：文件名中列出（一如既往），但它背後的信息。
我真的很感謝任何關於如何解決這個問題的方法或者其他有效解決這個問題的方法。我對編程只有一點基本的瞭解，但我一定能夠將自己融入到任何簡單的解決方案中。最好的幫助將是一種優化批處理代碼以適應此問題的方法。如果缺少一些信息，我很抱歉，我會提供。
我不認爲一個人可以設置'％3'，因爲它是參數重定向重定向的
commands輸出。 – SteveFest我建議使用本機支持XML格式的語言來操作XML數據，因爲純批處理腳本可能很容易違反規範並使數據無法訪問...... – aschipfl